Il-13 and IFN-gamma: interactions in lung inflammation

Area of Science:

• Immunology
• Pulmonology
• Cell Biology

Background:

• Chronic lung inflammation, including asthma, often involves mixed T helper cell type 2 (Th2) and T helper cell type 1 (Th1) responses.
• Key cytokines involved are interleukin-13 (IL-13) from Th2 cells and interferon-gamma (IFN-γ) from Th1 cells.
• The interplay between these cytokines in lung inflammation remains incompletely understood.

Purpose of the Study:

• To investigate the impact of IFN-γ and IL-13 on airway inflammation and hyperreactivity.
• To elucidate the modulatory role of IFN-γ on IL-13-induced lung responses.
• To understand the ambiguous role of Th1 responses in Th2-mediated lung injury.

Main Methods:

• Mouse models of airway inflammation induced by mixed T cell responses.
• Administration of recombinant cytokines (IFN-γ and IL-13) intranasally.
• Assessment of airway hyperreactivity, goblet cell hyperplasia, inflammation, and immune cell populations.

Main Results:

• In mixed responses, Th1 cells (IFN-γ+) correlated negatively with airway hyperreactivity.
• IL-13 blockade partially reduced airway hyperreactivity and goblet cell hyperplasia in mixed responses, but not inflammation.
• In polarized Th2 responses, IL-13 blockade significantly inhibited airway hyperreactivity, goblet cell hyperplasia, and inflammation.
• IFN-γ inhibited IL-13-induced goblet cell hyperplasia and airway eosinophilia.
• Concurrently, IFN-γ and IL-13 showed potentiation, increasing IL-6, NK cells, and CD11c+ cells expressing MHC II and CD86.

Conclusions:

• IFN-γ exhibits dual effects on IL-13-induced lung changes: inhibition of some responses and potentiation of others.
• This dual action of IFN-γ may explain the variable contribution of Th1 responses to Th2-driven lung pathology.
• Understanding this cytokine crosstalk is crucial for managing inflammatory lung diseases.